Stay updated on Pembrolizumab in Neoplasms Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neoplasms Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant changes to core study information were detected; the updates appear to be formatting or copy edits rather than changes to eligibility, endpoints, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:03:07.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a government operating-status notice and updated the version to v3.2.0; removed the previous v3.1.0 version reference.
    Difference
    2%
    Check dated 2025-10-06T08:44:56.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.1%
    Check dated 2025-09-29T07:32:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page update is a minor version bump from v3.0.1 to v3.0.2; a small 'Back to Top' element was removed, with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-14T23:10:55.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T19:46:37.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location related to Hemic and Lymphatic Diseases, while several specific disease-related terms and previous version information have been removed.
    Difference
    2%
    Check dated 2025-08-31T12:34:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neoplasms Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.